Outset Medical, Inc.

OM Healthcare Medical Devices

Outset Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $119.5 million, up 5.09% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 6.73%, free cash flow fell 90.5% and total debt rose 4.20%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

3.94 0.14 −3.43%
Market cap
$76.6M
P/E
0.0×
Fwd P/E
−1.1×
Dividend yield
—
F-score
6/9
Altman Z
−5.37
Beneish M
−3.25
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

6 6 4 4
ROE
(94.23%) (106.20%) (53.90%) (60.09%)
ROA
(30.80%) (30.23%) (27.18%) (27.97%)
ROIC
(74.83%) (76.86%) (80.83%) (86.10%)
Return on Tangible Assets
(37.65%) (37.47%) (36.84%) (39.59%)
Average Days of Receivables
100.20 86.55 78.60 90.54
Free Cash Flow per Share
(3.03) (3.10) (1.86) (2.09)
Free Cash Flow
(53.91) (47.12) (34.25) (38.88)
Capital Expenditures
(0.62) (0.80) (0.74) (0.56)
Other line items
Cash ROIC
(12.94%) (12.02%) (9.37%) (11.36%)
Accounts Receivable Turnover
3.57 3.74 3.78 3.67
Accounts Payable Turnover
24.85 32.94 53.45 23.26
Inventory Turnover
1.35 1.36 1.32 1.38
Average Days of Payables
8.41 2.78 7.53 23.70
Days of Inventory on Hand
240.52 238.96 259.62 251.73
Tax Rate
0.01 0.01 0.01 0.01
Research and Development Expense of Revenue
20.05% 17.77% 18.15% 18.25%
Selling, General and Administrative Expense of Revenue
76.74% 77.19% 79.66% 79.57%
Share Based Compensation of Revenue
13.74% 13.07% 13.69% 12.98%
Interest Coverage
(4.34) (4.78) (4.89) (4.81)
Operating CF/Net income
0.61 0.57 0.45 0.52
Depreciation/Fixed assets
0.44 0.45 0.39 0.35
Capex/Depreciation
(0.27) (0.38) (0.47) (0.43)
Revenue per Share
6.75 7.85 6.40 6.33
Operating CF per Share
(3.00) (3.05) (1.82) (2.06)
Capex per Share
(0.03) (0.05) (0.04) (0.03)
Capex to Sales
0.01 0.01 0.01 0.00

Fold the line items

Columns are period end dates